Renewed Skin Starts Here Trio

Noticing early signs of your skin starting to change? This is the set for you. This powerful trio is your starting point for visibly firmer, smoother, and plump-looking skin. Specially formulated with a gentle, slow-release form of Retinol, our Retinol Serum and Retinol Eye Cream are the perfect introduction to retinoids and help to renew skin's appearance by visibly targeting the first signs of aging and hyperpigmentation. Paired with Bio-Active Ceramide Moisturizer to help strengthen the skin’s barrier, provide 24-hr hydration, and accelerate visible skin renewal, the Renewed Skin Starts Here set will support your skin through its next era.  ​

TREAT – Retinol Serum: The perfect starter Retinol, specially formulated with a gentle Retinol to help avoid irritation. Hero ingredient Retinyl Acetate works to gently resurface and enhance skin cell turnover, improving appearance of fine lines, wrinkles and overall skin tone and texture. 96% of first-time Retinol users found the serum gentle enough for daily application*. ​

TREAT – Retinol Eye Cream: A night eye cream for first signs of aging, helps to smooth, rejuvenate, and visibly reduce fine lines and wrinkles whilst giving extra support to your most fragile skin. Formulated with slow-release Vitamin A derivatives that help to avoid irritation.​

MOISTURIZE – Bio-Active Ceramide Moisturizer: Powered by Bio-Active Ceramides for up to 4X visible fine line & wrinkle reduction**, this rich, velvety moisturizer defends against visible signs of skin aging. Clinically proven to plump, firm and visibly lift in 28 days**, it delivers multi-level support to help strengthen the moisture barrier, provide 24hr hydration and accelerate visible renewal for skin. Compared with traditional ceramides, next-generation Bio-Active Ceramides go beyond barrier repair to reset, strengthen, and protect skin through multiple layers. ​

* 6-week independent consumer trial of 61 people ​

** Results delivered by 0.2% Ceramide NP. 12-week clinical study of 30 people, compared to a placebo formulation​

**4-week clinical study of 20 people